Michael Ling, PhD

Michael Ling, PhD, earned his doctorate from the University of Guelph and completed a postdoctoral fellowship at the Hospital for Sick Children and the University of Toronto. A seasoned laboratory researcher and life science industry executive, he has significant expertise in laboratory supply, distribution, and cold chain logistics. Michael is a prolific inventor and technology developer, having successfully launched multiple medical devices across the U.S., Canada, and Europe. He currently serves as the CEO of GeneBio Systems, Inc., and is a board member of ViroCarb Inc. Additionally, he has held roles as a professor at Seneca College and as VP of Research and Development at Viracor-IBT (now part of Eurofins).